Tactio adds scale to RPM platform
BOSTON – Tactio Health Group has added Terraillon’s WebCoach Form scale to its DOCAPOST remote patient monitoring platform to enable remote obesity management programs in France. “We are now able to develop use cases for a wider range of patients, including seniors with obesity related health issues,” said Michel Nadeau, CEO of Tactio Health Group, in a statement. The company is integrating the scale into its DOCAPOST platform to link obese patients with clinical care teams that can track and coach them remotely. TactioRPM is an app-enabled platform that combines mobile apps, connected health integrations, patient questionnaires, digital coaching programs and HIPAA-compliant messaging. Powering telehealth initiatives from payers, providers and pharma, its clinical applications include chronic disease monitoring, population health screening, clinical research and post-acute care.
Pneuma develops digital inhaler
BOONE, N.C. – Early clinical studies have shown that a fully digital, soft mist inhaler developed by Pneuma Respiratory can effectively deliver a number of different types of medicines to the lungs. “More than 40 million people suffer from asthma or COPD in the U.S.,” said James Bauler, director of business development at Pneuma Respiratory. “It’s well documented that patients have problems adopting the correct inhaler technique and thus receiving the expected dose of medication both with dry powder and existing metered-dose inhalers. With a proven team of technology and health care leaders, Pneuma expects to make significant gains in pulmonary drug delivery.” The device uses electronic breath actuation and a soft mist ejector. As a patient inhales, the ejector senses the breath and activates automatically. This allows the medication droplets to ride into the lungs on the patients’ breath, without propellants. Paired with a mobile app, the device is capable of delivering real-time dose verification data. Two clinical studies with COPD patients using small-molecule asthma and COPD medications validated the platform using bronchodilation as the outcome. A feature of the device is its ability to deliver different sized droplets of medicine via its droplet ejector technology, which allows the device to potentially target different areas of the lungs, said Bauler.
Microsoft teams with Green Bay Packers for tech development
GREEN BAY, Wis. – The Green Bay Packers and Microsoft have launched TitletownTech, a partnership aimed at boosting economic expansion in the state’s Fox River Valley and beyond by bringing world-class digital innovations and expertise to Green Bay. Operating from a state-of-the-art work space in the Titletown development next to Lambeau Field, TitletownTech will help the region’s emerging and existing businesses, including health care startups, define and build new digital products, transform their operations through technology, and in some cases, provide capital to launch new ventures. “Economic development is the key to our region’s future, and Microsoft, with its array of tools and expertise will help grow new businesses, as well as assist our existing companies to use technology to realize greater success,” said Mark Murphy, president and CEO of the Green Bay Packers, in a statement.
Microsoft and the Packers are each planning to commit $5 million in TitletownTech over the next five years, and have pledged to donate all profits and capital returns from the venture capital fund to philanthropy and economic development. The new building that will house TitletownTech will open next fall. Microsoft’s participation in TitletownTech is part of the company’s TechSpark program, which is developing new digital initiatives in six local U.S. communities outside major metropolitan cities to foster job creation and economic growth.
FDA approves digital pill
WASHINGTON – The U.S. Food and Drug Administration approved the first drug in the U.S. with a digital ingestion tracking system. Abilify MyCite has an ingestible sensor embedded in the pill that records that the medication was taken. “The FDA supports the development and use of new technology in prescription drugs and is committed to working with companies to understand how technology might benefit patients and prescribers,” said Dr. Mitchell Mathis, director of the division of psychiatry products in the FDA’s Center for Drug Evaluation and Research. The system works by sending a message from the pill’s sensor to a wearable patch, which transmits the information to a mobile app so that patients can track the ingestion of the medication on their smart phone. Patients can also permit their caregivers and physician to access the information through a web-based portal.
Intel, Aventyn collaborate on connected care
BOSTON – Intel is working with connected health company Aventyn on smart Internet of Things-connected health solutions and services, including commercialization of integrated clinical evidenced solutions for hospitals and health care providers. “The time is now to accelerate innovation at the edge of care to make remote care models the new standard of care, which is critically needed to bend the cost curve down and the outcomes curve upward,” said David Ryan, general manager health sector, Intel IoT Group, in a statement. The two companies are combining Intel’s recently-launched Health Application Platform for connected health care with Aventyn’s Vitalbeat integrated remote monitoring and management system for providers, payers and pharma/life science companies. The goal: to improve chronic disease patient population management, and prevent avoidable readmissions with advanced patient engagement at lower costs and better outcomes. “This innovative technology helps our health care partners advance delivery of reliable remote care solutions,” said Navin Govind, founder and CEO of Aventyn, in a statement.
CEP America launches remote acute neurology services
EMERYVILLE, Calif. – CEP America, a physician‐owned partnership, has launched an acute neurology practice—a single solution for the integration of teleneurology, telestroke, neurohospitalist, neuro-diagnostic and other neurology specialty services. “Our experienced acute neurologists and industry-leading services will help hospitals broaden their expertise to serve more patients in a more effective way,” said Dr. Imamu Tomlinson, CEO of CEP America, in a statement.
The services are being provided through a partnership with SAGE NeuroHospitalist Management Group and Riverside Community Hospital. CEP America’s teleneurology service will allow hospitals to provide a broader range of services to patients through around-the-clock access to specialty-trained neurologists for remote consultations and remote patient interviewing. The neurohospitalist service will offer customized support through virtual and/or onsite consultations for patients. “Our hope is to expand access to the latest technologies and practices so hospitals can deliver best-in-class patient care, and CEP is bringing this vision to life,” said Dr. Arbi Ohanian, vice president for acute neurology at CEP America, in a statement.
Glooko’s mHealth app improves glycemic control in people with diabetes
MOUNTAIN VIEW, Calif. & GOTHENBURG, Sweden – Glooko’s Mobile Insulin Dosing System can help improve glycemic control of people with Type 2 diabetes, a recent three-week study showed. MIDS decreased mean blood glucose, reduced the rate of hyperglycemic events and increased in-range blood glucose readings of participants, according to the study. “We are thrilled to see early clinical evidence show the positive impact the Glooko Mobile Insulin Dosing System can have on people with diabetes,” said Rick Altinger, CEO of Glooko, a provider of diabetes data management solutions, in a statement. The goal of the MIDS mHealth application, which is currently available only for investigational use, is to improve glycemic outcomes and increase adherence to a long-acting insulin regimen.
Claris Healthcare introduces wearable monitoring for TKR patients
WASHINGTON – Claris Healthcare has launched Claris Reflex, a medical device and patient monitoring system for patients who have had total knee replacement. Designed specifically for patients aged 65 and older, Claris Reflex is a coaching system that allows providers to better manage patients under the new bundled payment for total knee replacement program. Patients receive a wearable activity tracking sensor and tablet, and caregivers are provided access to an online dashboard that allows them to monitor patients remotely around the clock.
“Claris Reflex allows patients to confidently and independently manage their pre- and post-surgical recovery in their own home,” said Geof Auchinleck, CEO of Claris Healthcare, in a statement.
Tunstall, TELUS develop remote monitoring platform
TORONTO – Tunstall Healthcare and TELUS Health have developed the ICP Integrated Care Platform for patients with chronic diseases. The platform uses remote monitoring and videoconferencing telehealth software to allow patients to self-manage their condition and avoid hospital admissions. “Creating tools that allow patients to partner with their caregivers to manage their own health is a foundational step in our pursuit of a fully integrated health care ecosystem,” said Dr. Michael Guerriere, chief medical officer of TELUS Health, in a statement. By enabling patients to track and upload their own vital signs from home, the TELUS Home Health Monitoring solution powered by ICP, allows virtual care teams to monitor biometrics in real-time and intervene before a health issue arises, regardless of where they are located. “With the growing numbers of citizens living with long-term conditions and increased expectations of care delivery, health care providers are under continued pressure to deliver new models of care and improve patient outcomes through the adoption of technology-enabled care systems such as ICP,” said Gordon Sutherland, CEO of Tunstall Healthcare Group, in a statement.
iReliev introduces wearable EMS/TENS device for chronic pain
SOUTHLAKE, Texas – iReliev has introduced the PlayMakar wireless EMS/TENS unit, a wearable tool that helps treat acute and chronic pain symptoms. “We’ve set out to develop the world’s most convenient and easiest to use wearable therapy device on the market,” said Mike Williams, CEO of ExcelHealth, maker of iReliev products, in a statement. The PlayMakar uses transcutaneous electrical nerve stimulation and electrical muscle stimulation. Two rechargeable receivers connect to electrode pads for wireless application, and receivers and pads can be placed at any point of pain or muscle soreness, including on joints afflicted with arthritis. Additional receivers can be added on to cover larger treatment areas or muscle groups.
Data sources for clinical trials on the rise, report finds
BOSTON and PLEASANTON, Calif. – The volume and diversity of data sources used in clinical trials are expected to increase significantly over the next three years, a report from the Tufts Center for the Study of Drug Development says.
The 2017 eClinical Landscape Study found that 97% of companies say they will increase use of at least one clinical data source to make faster, more accurate decisions during trials. However, 98% of respondents currently report challenges with their clinical data management systems, indicating that companies will need to be better prepared to collect and analyze the growing volume of real-world patient data available from a variety of sources.
“Clinical trial complexity is challenging scientific, operating and technology solution domains,” said Ken Getz, research associate professor and director at the Tufts Center for the Study of Drug Development, in a statement. “At the same time that clinical teams are managing traditional data from case report forms and local and central labs, they are being forced to step out of their comfort zone to manage, integrate and analyze data from more diverse and less compatible sources, including smart phone and wearable devices, real-world evidence and social media.”
Life sciences companies use an average of four data sources in clinical trials today. In three years, the number of data sources utilized is projected to increase to six, with 70% of companies planning to use a new data source that they are not leveraging today.
The survey also showed significant changes in the range of clinical information organizations plan to use in the next three years. A majority of companies plan to use mHealth and smart phone data (each increasing 47%) and eSource data (increasing 46%).
The 2017 eClinical Landscape Study was sponsored by Veeva Systems and reviewed the state of data management in life sciences with an in-depth look at the insights and opinions of clinical data management professionals at more than 250 companies.
Illinois organizations receive telehealth excellence awards
CHICAGO – The Partnership for a Connected Illinois, in partnership with the American Telemedicine Association, presented its 2017 Awards for Excellence in Telehealth Leadership last week.
The Awards for Excellence in Telehealth Leadership are given to organizations that have made exceptional contributions to advancing telehealth in Illinois on behalf of their members, employees, communities, providers and patients.
This year’s recipients are:
Improved Care for Underserved Populations:
- Leadership Award: Illinois Telehealth Network
- Achievement Award: Rush University Medical Center Tele-Stroke Network
Improved Policy Changes to Advance Telehealth:
- Leadership Award: Presence Health
Advancing Telehealth by Innovation:
- Leadership Award: Regroup Therapy
- Achievement Award: TelePharm
Partnership for a Connected Illinois was formed to ensure broadband access throughout Illinois and to maximize its impact and adoption.
mHealth experts develop recommendations for using consumer data
DURHAM, N.C. – The Duke-Margolis Center for Health Policy recently gathered several experts to form recommendations on accelerating the use of mHealth technologies for research on medical treatments.
“There is not yet a clear path for how mHealth technologies can reliably and efficiently elicit, validate and transmit relevant data, and such data are currently not being collected on a sustained and longitudinal basis,” wrote the authors of the recently released report, “Mobilizing mHealth Innovation for Real-World Evidence Generation.”
The aim of the working group of experts from throughout the health care and mHealth ecosystem was to create collaborations between the patient, clinical and research communities, and mHealth companies to advance the science on collecting and using mHealth data for evidence generation.
The group made several recommendations in its report, including:
- Establish a learning research community to advance the development and use of patient/consumer-facing mHealth technologies in evidence generation;
- Ensure efficient access to well-characterized, standardized and robust user-generated health data; and
- Use mHealth to promote easier participation in research through the awareness of and adoption of standardized approaches for informed consent and patient privacy.
“Mobile health data for novel real-world evidence generation have the potential to transform health care,” wrote the report’s authors. “The steps described here can help harness the power of mHealth to achieve this transformation while balancing the needs of the patient/consumer, researchers and the mHealth companies in a responsible, ethical and empowering way.”